Alopecia Treatment Market, By Drug Class (Corticosteroids, 5 AR Inhibitors, Vasodilators, Others), By Disease Type (Alopecia Areata, Androgenic Alopecia, Traction Alopecia, Others), By Route of Administration (Topical, Oral, Injectable Topical application
Description
Alopecia is the medical term for hair loss. Hair loss can happen naturally or as a result of a disease or the use of certain medications. Some common types of alopecia include:
Market players are focused on product launches or approvals, which is expected to drive growth of the global alopecia treatment market over the forecast period. For instance, in September 2021, Dr. Reddy's Laboratories Limited announced the launch of Minoxidil topical solution USP 2% and 5% for the treatment of female pattern hair loss (FPHL). Dr. Reddy's will market its products as Mintop 2 percent and Mintop Eva 5 percent, respectively. The launch comes after the Central Drugs Standard Control Organization (CDSCO) in India approved the use of Minoxidil topical solution USP 2% and 5% for the treatment of FPHL for the first time.
Market players are focused on inorganic strategies such as acquisitions, partnerships, and agreements with other market players. This is expected to drive the market growth over the forecast period. For instance, in August 2017, Aclaris Therapeutics, Inc., a biopharmaceutical company based in the U.S. acquired Confluence Life Sciences, Inc., which expanded Aclaris’ inflammation and immunology pipeline with the addition of Confluence’s lead product candidates CDD-450, topical Janus kinase inhibitors, and IL2-inducible T-cell kinase inhibitor programs.
Moreover, market players are focused on research and development activities is expected to propel the growth of the global alopecia treatment market. For instance, in August 2021, Pfizer Inc., a multinational biopharmaceutical company announced positive top-line results from the Phase 2b/3 ALLEGRO trial, which evaluated oral once-daily ritlecitinib in patients with alopecia areata, an autoimmune disease characterized by an immune attack on hair follicles that causes hair loss on the scalp and can also affect the face and body.
Key features of the study:
- Androgenic alopecia is common in both men and women. It is also referred to as male- or female-pattern hair loss.
- Alopecia areata- Alopecia areata is also known as patchy baldness. Bald patches can appear anywhere on the body, but the majority of people get a round or oval patch on the scalp.
- Traction alopecia is caused by putting stress on the hair by pulling or stretching it repeatedly
Market players are focused on product launches or approvals, which is expected to drive growth of the global alopecia treatment market over the forecast period. For instance, in September 2021, Dr. Reddy's Laboratories Limited announced the launch of Minoxidil topical solution USP 2% and 5% for the treatment of female pattern hair loss (FPHL). Dr. Reddy's will market its products as Mintop 2 percent and Mintop Eva 5 percent, respectively. The launch comes after the Central Drugs Standard Control Organization (CDSCO) in India approved the use of Minoxidil topical solution USP 2% and 5% for the treatment of FPHL for the first time.
Market players are focused on inorganic strategies such as acquisitions, partnerships, and agreements with other market players. This is expected to drive the market growth over the forecast period. For instance, in August 2017, Aclaris Therapeutics, Inc., a biopharmaceutical company based in the U.S. acquired Confluence Life Sciences, Inc., which expanded Aclaris’ inflammation and immunology pipeline with the addition of Confluence’s lead product candidates CDD-450, topical Janus kinase inhibitors, and IL2-inducible T-cell kinase inhibitor programs.
Moreover, market players are focused on research and development activities is expected to propel the growth of the global alopecia treatment market. For instance, in August 2021, Pfizer Inc., a multinational biopharmaceutical company announced positive top-line results from the Phase 2b/3 ALLEGRO trial, which evaluated oral once-daily ritlecitinib in patients with alopecia areata, an autoimmune disease characterized by an immune attack on hair follicles that causes hair loss on the scalp and can also affect the face and body.
Key features of the study:
- This report provides an in-depth analysis of global alopecia treatment market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global alopecia treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
- Key companies covered as a part of this study include Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy’s Laboratories Ltd., Himalaya Wellness Company, Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global alopecia treatment market.
- Global Alopecia Treatment Market, By Disease Type:
- Alopecia Areata
- Androgenic Alopecia
- Traction Alopecia
- Others
- Global Alopecia Treatment Market, By Drug Class:
- Corticosteroids
- 5 AR Inhibitors
- Vasodilators
- Others
- Global Alopecia Treatment Market, By Route of Administration:
- Topical
- Oral
- Injectable
- Global Alopecia Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Alopecia Treatment Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Aclaris Therapeutics, Inc.
- Fagron
- Follicum AB
- Cipla Inc.
- Arcutis Biotherapeutics
- Dr. Reddy’s Laboratories Ltd.
- Himalaya Wellness Company
- Eli Lilly and Company
- Concert Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
Table of Contents
193 Pages
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Disease Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Recent Trends
- Mergers, Acquisitions, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER’s Analysis
- 4. Global Alopecia Treatment Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Alopecia Treatment Market, By Drug Class, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- 5 AR Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Vasodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- 6. Global Alopecia Treatment Market, By Disease Type, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Alopecia Areata
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Androgenic Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Traction Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- 7. Global Alopecia Treatment Market, By Route of Administration, 2020 – 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- 8. Global Alopecia Treatment Market, By Distribution Channel, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- 9. Global Alopecia Treatment Market, By Region, 2020 – 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- North America
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020 - 2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
- 10. Competitive Landscape
- Company Profiles
- Stemson Therapeutics .
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- OliX Pharmaceuticals
- Pfizer Inc
- Aclaris Therapeutics
- Fagron,
- Follicum AB
- Cipla Inc.
- Arcutis Biotherapeutics
- Dr. Reddy’s Laboratories Ltd
- Himalaya Wellness Company
- Cosmo Pharmaceuticals N.V.
- Equillium, Inc.
- Eli Lilly and Company
- Concert Pharmaceuticals Inc
- Teva Pharmaceutical Industries Ltd.
- Analysts’ Views
- 11. Section
- References
- Research Methodology
- About Us and Sales Contact
- *Browse 34 market data tables and 24 figures on “Global Alopecia Treatment Market” – Global forecast to 2032
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
